BE
BE · BE · BE-AMP-SAM590213-00
Rinvoq 30 mg
ATC L04AF03
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerAbbVie Deutschland
CountryBE (BE)
ATC codeL04AF03
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 3
- be_apb4404877
- be_apb7737224
- be_apb4404885
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Prolonged-release tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Rinvoq 30 mg",
"name_fr": "Rinvoq 30 mg",
"name_nl": "Rinvoq 30 mg",
"amp_code": "SAM590213-00",
"strengths": [
"30.0000"
],
"pack_count": 4,
"substances": [
"Upadacitinib Hemihydrate",
"Upadacitinib"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Upadacitinib",
"authorisation_numbers": [
"EU/1/19/1404/006",
"EU/1/19/1404/007",
"EU/1/19/1404/009",
"EU/1/19/1404/008"
]
}Related drugs
Other records sharing ATC code L04AF03.
Access this data programmatically
Query Rinvoq 30 mg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.